Citi Upgrades Bellicum Pharmaceuticals (BLCM) to Buy

August 9, 2016 7:33 AM EDT
Get Alerts BLCM Hot Sheet
Price: $13.12 -4.79%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 11
Trade BLCM Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Citi upgraded Bellicum Pharmaceuticals (NASDAQ: BLCM) from Neutral to Buy with a price target of $24.00.

For an analyst ratings summary and ratings history on Bellicum Pharmaceuticals click here. For more ratings news on Bellicum Pharmaceuticals click here.

Shares of Bellicum Pharmaceuticals closed at $17.05 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment